drugset / Trial / NCT00333944

Study to Know the Efficacy of Higher Doses of Pralidoxime in Patients of Organophpsphorus Poisoning.

NCT00333944 ↗

Completed 200 enrolled Giriraj Hospital
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine whether high doses of pralidoxime(PAM) are effective as compare to lower doses of PAM in the management of moderately sever organophosphorus poisoning patients.

Timeline

Start
2000-05
Primary completion
—
Completion
2003-06

Outcome

Met primary endpoint

paper required less atropine during the first 24 h than controls (median 6 mg vs 30 mg; difference 24 mg [95% CI 24-26, p<0.0001]). PMID 17174705 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Pralidoxime Small molecule 1 g Intravenous